Astera Labs, Inc. $ALAB Shares Sold by Simplicity Wealth LLC

Simplicity Wealth LLC lessened its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 11.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,750 shares of the company’s stock after selling 1,425 shares during the quarter. Simplicity Wealth LLC’s holdings in Astera Labs were worth $1,178,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in ALAB. Warm Springs Advisors Inc. acquired a new position in Astera Labs during the first quarter worth about $2,908,000. Hsbc Holdings PLC increased its holdings in Astera Labs by 116.5% in the first quarter. Hsbc Holdings PLC now owns 181,297 shares of the company’s stock valued at $19,808,000 after buying an additional 97,576 shares in the last quarter. Whipplewood Advisors LLC lifted its position in shares of Astera Labs by 15,950.0% during the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after acquiring an additional 319 shares during the period. Summit Securities Group LLC acquired a new stake in shares of Astera Labs during the 1st quarter valued at approximately $80,000. Finally, Mason & Associates Inc purchased a new stake in shares of Astera Labs during the 1st quarter worth approximately $235,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the transaction, the director directly owned 57,466 shares in the company, valued at $25,859,700. The trade was a 5.75% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,040,691 shares of company stock worth $507,675,380 over the last three months. Company insiders own 10.40% of the company’s stock.

Analysts Set New Price Targets

ALAB has been the topic of a number of research reports. Barclays upped their price target on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Jefferies Financial Group reiterated a “buy” rating and set a $270.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Roth Capital restated a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Stifel Nicolaus lifted their price target on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $265.75.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $412.97 on Monday. Astera Labs, Inc. has a 52-week low of $88.18 and a 52-week high of $499.48. The stock’s fifty day simple moving average is $335.76 and its 200-day simple moving average is $214.94. The company has a market capitalization of $70.79 billion, a P/E ratio of 279.03, a P/E/G ratio of 4.65 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter last year, the business posted $0.33 EPS. The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 1.88 earnings per share for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.